ARVINAS, INC. — Director's Dealing 2021

Mar 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2021-02-26

Reporting Person: Houston John G (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-30	Common Stock	A	315	$28.50	Acquired	817938	Direct
2020-12-31	Common Stock	A	310	$29.02	Acquired	818248	Direct
2021-03-02	Common Stock	M	17510	—	Acquired	835758	Direct
2021-03-02	Common Stock	S	8115	$77.4495	Disposed	827643	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-26	Stock Option (right to buy)	$78.30	A	219500	Acquired	2031-02-25	Common Stock (219500)	Direct
2021-03-02	Restricted Stock Units	$	M	17510	Disposed		Common Stock (17510)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	817623	Direct

Footnotes

F1: On March 23, 2020, the reporting person filed a Form 4 that incorrectly disclosed the sale of shares of common stock to cover withholding taxes following the vesting of previously granted Restricted Stock Units. The correct number of shares sold was 5,542, not 5,405, reducing the number of securities beneficially owned by the reporting person by 137 shares.

F2: The shares were acquired under the 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F3: Includes 315 shares acquired under the 2018 Employee Stock Purchase Plan.

F4: Includes an aggregate of 625 shares acquired under the 2018 Employee Stock Purchase Plan.

F5: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.

F6: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

F7: The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $77.4495.

F8: This option award was granted on February 26, 2021. 1/4 of the shares underlying the award shall vest on February 26, 2022, with the remainder of the shares vesting in equal monthly installments following February 26, 2022 through February 26, 2025.

F9: On March 1, 2019, the reporting person was granted 70,042 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.